EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of microRNAs in Lung Cancer: Mechanisms, Diagnostics and Therapeutic Potential

Elżbieta Bartoszewska iD, Piotr Misiąg iD, Melania Czapla iD, Katarzyna Rakoczy, Paulina Tomecka, Michał Filipski iD, Elżbieta Wawrzyniak-Dzierżek iD, Anna Choromańska iD

International Journal of Molecular Sciences · 15.04.2025 · 26 (8) · 3736

DOI: 10.3390/ijms26083736 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.04.2025. Verfasst von Elżbieta Bartoszewska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Wroclaw Medical University, Mikulicza-Radeckiego 5, 50-345 Wroclaw, Poland. Hauptthemen laut MEDLINE: Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Department of Molecular and Cellular Biology of Wroclaw Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) are small RNA molecules that do not have coding functions but play essential roles in various biological processes. In lung cancer, miRNAs affect the processes of tumor initiation, progression, metastasis, and resistance to treatment by regulating gene expression. Tumor-suppressive miRNAs inhibit oncogenic pathways, while oncogenic miRNAs, known as oncomiRs, promote malignant transformation and tumor growth. These dual roles position miRNAs as critical players in lung cancer biology. Studies in recent years have shown the significant potential of miRNAs as both prognostic and diagnostic biomarkers. Circulating miRNAs in plasma or sputum demonstrate specificity and sensitivity in detecting early-stage lung cancer. Liquid biopsy-based miRNA panels distinguish malignant from benign lesions, and specific miRNA expression patterns correlate with disease progression, response to treatment, and overall survival. Therapeutically, miRNAs hold promise for targeted interventions. Strategies such as miRNA replacement therapy using mimics for tumor-suppressive miRNAs and inhibition of oncomiRs with antagomiRs or miRNA sponges have shown preclinical success. Key miRNAs, including the let-7 family, miR-34a, and miR-21, are under investigation for their therapeutic potential. It should be emphasized that delivery difficulties, side effects, and limited stability of therapeutic miRNA molecules remain obstacles to their clinical use. This article examines the roles of miRNAs in lung cancer by indicating their mechanisms of action, diagnostic significance, and therapeutic potential. By addressing current limitations, miRNA-based approaches could revolutionize lung cancer management, offering precise, personalized, and minimally invasive solutions for diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsMicroRNAsHumansBiomarkers, TumorGene Expression Regulation, NeoplasticAnimals

Stichwörter der Autor:innen

diagnostic biomarkersliquid biopsylung cancermicroRNAspersonalized medicineprognostic biomarkerstargeted therapy

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Faculty of Medicine, Wroclaw Medical University, Mikulicza-Radeckiego 5, 50-345 Wroclaw, Poland.
  • Student Research Group No. K148, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.
  • Department and Clinic of Bone Marrow Transplantation, Oncology and Pediatric Hematology, Borowska 213, 50-556 Wroclaw, Poland.
  • Department of Molecular and Cellular Biology, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.

ORCID-Profile: Elżbieta Bartoszewska, Piotr Misiąg, Melania Czapla, Michał Filipski, Elżbieta Wawrzyniak-Dzierżek, Anna Choromańska

Förderung

  • the Department of Molecular and Cellular Biology of Wroclaw Medical University

Zitieren

APA

Bartoszewska, E., Misiąg, P., Czapla, M., Rakoczy, K., Tomecka, P., Filipski, M., Wawrzyniak-Dzierżek, E., & Choromańska, A. (2025). The Role of microRNAs in Lung Cancer: Mechanisms, Diagnostics and Therapeutic Potential. International Journal of Molecular Sciences, 26(8), 3736. https://doi.org/10.3390/ijms26083736

Vancouver

Bartoszewska E, Misiąg P, Czapla M, Rakoczy K, Tomecka P, Filipski M, et al. The Role of microRNAs in Lung Cancer: Mechanisms, Diagnostics and Therapeutic Potential. International Journal of Molecular Sciences. 2025;26(8):3736. doi:10.3390/ijms26083736

BibTeX
@article{Bartoszewska2025,
  author = {Bartoszewska, Elżbieta and Misiąg, Piotr and Czapla, Melania and Rakoczy, Katarzyna and Tomecka, Paulina and Filipski, Michał and Wawrzyniak-Dzierżek, Elżbieta and Choromańska, Anna},
  title = {The Role of microRNAs in Lung Cancer: Mechanisms, Diagnostics and Therapeutic Potential},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {8},
  pages = {3736},
  doi = {10.3390/ijms26083736}
}
Kostenlos starten →